Finally, the analysis of the CPTAC dataset showed that the expression levels of the total CTHRC1 protein were enhanced in primary breast cancer, ovarian cancer, colon cancer, clear cell RCC, UCEC and LUAD compared with normal tissues (Additional file 4: Fig. S4b). This evidence concerns the gene CTHRC1 and ovarian carcinoma.